glp-1 muscle spasms Balancing weight and loss in GLP1 receptor agonist therapy GLP-1 receptor agonists | How

[7] Much research has demonstrated a direct correlation between a breakdown in the glutathione system and autoimmune disease

Terminal diseases and palliative conditions The aim of treatment of lipid disorders is to reduce cardiovascular events and mortality, as well as overall mortality

Red flag symptoms requiring urgent medical assessment include: Severe abdominal pain or distension , particularly if accompanied by vomiting Complete inability to pass stools or wind (absolute constipation), especially with pain or distension Rectal bleeding or blood in the stool Unexplained weight loss beyond that expected from the medication's therapeutic effect Persistent nausea and vomiting preventing adequate oral intake Signs of bowel obstruction , such as colicky pain, absolute constipation, and abdominal distension Severe persistent abdominal pain radiating to the back , which may indicate pancreatitis Right upper abdominal pain, fever or yellowing of the skin/eyes , which could suggest gallbladder problems For urgent advice, contact NHS 111 or your GP

2020 Sep 16;10(1): 15218